![]() 2’,3’,5’-Tri-O-benzoyl-2’-β-C-methyl-5-methoxy uridine structure
|
Common Name | 2’,3’,5’-Tri-O-benzoyl-2’-β-C-methyl-5-methoxy uridine | ||
---|---|---|---|---|
CAS Number | 2072145-79-8 | Molecular Weight | 600.57 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C32H28N2O10 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of 2’,3’,5’-Tri-O-benzoyl-2’-β-C-methyl-5-methoxy uridine2’,3’,5’-Tri-O-benzoyl-2’-β-C-methyl-5-methoxy uridine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
Name | 2’,3’,5’-Tri-O-benzoyl-2’-β-C-methyl-5-methoxy uridine |
---|
Description | 2’,3’,5’-Tri-O-benzoyl-2’-β-C-methyl-5-methoxy uridine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
---|---|
Related Catalog | |
References |
Molecular Formula | C32H28N2O10 |
---|---|
Molecular Weight | 600.57 |